Store
The U.S. Market for Urgent Care Centers, 2nd Edition
Publication Date: September 23, 2020
Tags: Clinical Chemistry, COVID-19, Diagnostic Instruments, Hospital and Clinical, Imaging Instruments, Immunoassay, Pharmaceuticals, Point-of-Care (POC) Testing, Vaccines
Pages: 105
SKU: 20-042
Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2nd Edition, provides an in-depth analysis of this dynamic market, examining current trends, challenges, and opportunities for growth, especially in light of the COVID-19 pandemic.
Key Features of the Report:
This comprehensive report delivers essential data and insights for marketers and business planners, including:
- Urgent Care Services Overview: Analysis of the range of services provided by UCCs, from non-emergency acute care to specialized procedures.
- Market Size and Projections: Detailed market sizing and revenue projections segmented by reason for visit, forecasted to 2025.
- COVID-19 Impact: Examination of the effects of COVID-19 on urgent care centers, including test revenues and vaccine distribution.
- Current Trends: Insights into healthcare and insurance trends, competition, and market saturation.
- Key Metrics: Data on the number of locations, revenue per patient, startup costs, staffing, and ownership structures.
- Competitive Landscape: Profiles of major players, including market share and competitive strategies.
Market Insights:
- Growth and Challenges: While the urgent care market is expanding, there are trends that may limit growth. The report explores both the positive and negative impacts of these trends.
- Cost Savings Potential: Urgent care centers offer an affordable alternative to emergency room visits, with significant potential for cost savings. Transitioning non-emergency cases from ERs to UCCs could save up to $18.5 billion annually.
- Supplier Opportunities: UCCs represent a substantial market for pharmaceutical and IVD companies, offering opportunities for sales of point-of-care tests, immunoassays, clinical chemistry, imaging equipment, and vaccines.
Detailed Analysis:
- COVID-19: Impact on urgent care, including test revenues and vaccination efforts.
- Market Size by Visit Type: Detailed segmentation and revenue forecasts by type of visit.
- Supplier Sales: Analysis of sales opportunities for suppliers to UCCs.
- Competition: Examination of competition from new healthcare venues and the impact on UCCs.
- Demographics: Trends in urgent care utilization among seniors and other demographics.
Table: Respiratory Sales to U.S. Urgent Care Centers, by Segment, 2020-2025 ($ millions)
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Flu Revenue (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| Strep (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| RSV and Other (POC) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
| COVID-19 (POC & Send Out) | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
ONE: EXECUTIVE SUMMARY
Urgent Care Location Growth
-
- Figure 1-1: Urgent Care Locations and Growth 2013-2025
Definition of Urgent Care
The U.S. Healthcare Situation
Urgent Care Centers Market
- Urgent Care Market 2013-2025
The Definition of Urgent Care
The U.S. Healthcare Situation
Major Findings of the Report
Scope and Methodology
TWO: INTRODUCTION
-
- Table 2-1: Urgent Care Centers vs. Retail Clinics and Physician Practices
Business Model
Ownership by Type
The Need for Alternatives
High Cost of Care
Inconsistent Quality of Care
-
- Figure 2-1: Unnecessary Deaths Resulting From Variations in Health Care Quality, by Condition
Delays to Treatment
Patient Visits
-
- Figure 2-2: Patient Visit Trend
Revenue Per Patient
-
- Figure 2-3: Revenue Per Patient Trend
Location Growth
-
- Figure 2-4: Location Growth Trend
THREE: URGENT CARE CENTER MARKET
The Industry
Urgent Care Center Sales Forecasts
-
- Table 3-1: The U.S. Market for Urgent Care Clinic Services, 2013–2025
-
- Table 3-2: Urgent Care Sales by Type of Visit, 2020
-
- Table 3-3: Number of Urgent Care Centers Physicians
Competition
-
- Figure 3-1: Large Brand Clinics (More Than 10 Locations) vs. Other Clinics, 2020
-
- Figure 3-2: Major Urgent Care Providers, 2020
FOUR: URGENT CARE CENTER SUPPLIERS
-
- Table 4-1: Sales to Urgent Care Centers by Supplier Segment, (POC, Chemistry, Imaging, Vaccines)
POC Testing Sales to Urgent Cares
- The Industry
- Table 4-2: U.S. Professional POC Test Sales, 2011–2021
- POC Tests by Type
- Table 4-3: U.S. Professional POC Test Sales to Urgent Care Centers by Type of Test, 2011, 2016, 2021, in $ Millions
- Diabetes POC Testing
- HIV POC Testing
- Influenza POC Testing
- Pregnancy/Ovulation POC Testing
- Drugs of Abuse POC Testing
Clinical Chemistries, Sales to Urgent Cares
Vaccines, Vaccines Sales to Urgent Cares
- Diseases for Which Vaccines Are Available in the U.S., 2017
Urgent Care Center Sales Forecasts
COVID-19 Vaccines and Urgent Care Distribution
- Share of U.S. Vaccine Sales to Urgent Care Centers by Type of Vaccine
Imaging Equipment
- X-Ray Equipment
- Computer Tomography (CT) Equipment
- Ultrasound
- U.S. Market for X-Ray, Ultrasound and CT Equipment, 2011–2021
FIVE: COMPANY PROFILES
- American Family Care
- Banner Health
- Bellin Health
- Care Now
- CareSpot
- City MD
- Doctors Care
- Fast Pace Care
- FastMed
- Hometown Urgent Care
- Intermountain Instacare
- MDNow
- MedExpress Urgent Care
- Next Care
- Patient First
- Physicians Immediate Care
- Urgent Team
- U.S. Healthworks
Related products
COVID-19 Testing Markets, 2023
May 18, 2023
As the COVID-19 pandemic evolves into an endemic phase, the landscape of COVID-19 testing is changing rapidly. Kalorama Information’s COVID-19 Testing Markets, 2023 report provides crucial insights into this shifting market, answering key questions and providing valuable market sizing and estimates.
Key Insights Provided:
- Market impacts and trends in the evolving COVID-19 testing…
Price range: $4,000.00 through $6,000.00
Cell and Gene Therapy Funding and Deals Analysis, 2021-2023
December 8, 2023
Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…
Price range: $5,000.00 through $7,500.00
Histology and Cytology IVD Market Update, 2024
May 21, 2024
Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.
Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis…
Price range: $5,000.00 through $7,875.00
